Week 3 Introduction to Gynaecological Pathology Book Flashcards

1
Q

What is the function of LH?

A

Stimulation of progesterone production - triggering ovulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the function of HCG?

A

Stimulation of the corpus luteum to continue oestrogen and progesterone production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the function of Oestradiol?

A

Proliferation of the endometrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the function of FSH?

A

Stimulation of oestrogen production
Stimulation of ovarian follicular development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the function of progesterone

A

Stimulation of the endometrium to secrete glycogen-rich material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the function of GnRH

A

Stimulation of the release of pituitary hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or false Ovulation is triggered by a surge of LH production 12-24h prior to the ovulation.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or false: In case of pregnancy, the corpus luteum starts to produce hCG.

A

False, hCG is produced by the placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

True or false: GnRH is controlled by negative feedback of the gonadotropins.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

True or false: Day 1 of the menstrual cycle is defined as the first day after cessation of the menstruation.

A

False. Day 1 of the cycle is the first day of the menstrual period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or false: Changes in oestrogen and progesterone levels cause cyclic changes in the endometrium.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does the uterus, ovaries and endometrium change throughout the menstural cycle?

A

In the first part of the cycle (proliferative phase) the endometrium has a proliferative appearance and in the ovary you first detect a number of small follicles that have been recruited.

After a few days you can identify the dominant follicle increasing in size until ovulation.

Ovulation usually occurs when the follicle is approximately 20-22 mm, after which you can visualise a corpus luteum in the ovary. The endometrium becomes secretory in appearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What hormone do each of the following organs produce:
Pituitary gland
Plancenta
Hypothalamus
Uterus
Ovaries

A

Pituitary gland - LH, FSH
Plancenta - HCG
Hypothalamus - GnRH
Uterus - does not produce
Ovaries - Oestrogen and Progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain why exogenous administration of oestrogen and progestogen inhibits ovulation?

A

Both oestrogen and progestogen have an inhibitory effect on the hypothalamus and pituitary resulting in an inhibition of gonadotropin production.

Low FSH results in depressed follicular development but the dominant action for contraception is LH inhibition.

If there is no mid-cycle LH peak, ovulation will be inhibited even if follicular development occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Advantages of Tamoxifen?

A
  • Postmenopausal women with breast cancer, tamoxifen reduces mortality by 25 percent and recurrence by 50 percent.
  • Healthy women at high risk of developing breast cancer, tamoxifen found to reduce oestrogen receptor positive breast cancer risk by 45 percent.
  • Ability of maintaining bone mineral density, lowers incidence of osteoporotic fractures postmenopausal women.
  • Reduces cholesterol levels, especially LDL, with possibly a trend in lowering myocardial infarct incidence.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disadvantages of tamoxifen

A
  • Vaginal dryness and discharge.
  • Endometrial changes:
    increase in endometrial and endocervical polyps;
    increase in endometrial hyperplasia; and
    increase in endometrial carcinoma.
17
Q

What is the role of ultrasound in the monitoring of patients on tamoxifen?

A

The role of vaginal ultrasound in the monitoring of patients on tamoxifen is limited to the exclusion of pathology by visualising a thin endometrium.

Monitoring should happen pre-treatment and then yearly starting after two to three years of treatment in the asymptomatic patient. Investigation should be done immediately in case of symptoms, such as spotting, bleeding.

Vaginal ultrasound can be done as a first step and is, as said, useful when a thin endometrium is detected (less than 5 mm).

If the endometrium is more than 5 mm (in 75% of asymptomatic patients on tamoxifen), the only way to obtain a correct diagnosis is to do hydrosonography or hysteroscopy.

18
Q

Describe oestrogen only use

A

It is very important that patients know why they (who have not had a hysterectomy) need to take a combination of oestrogen and progesterone. Oestrogen will prevent/reduce osteoporosis and solve any menopausal symptoms but increase the risk of endometrial cancer during and after use, unless it is taken with adequate progestogen. Patients usually feel fine without the progesterone and it is only after a reasonably long period of time that problems will occur. Thirty percent of patients will develop atypical endometrial hyperplasia, a premalignant lesion, after three years.

The least you expect to find on Hilary’s ultrasound is a thick hyperplastic endometrium (with or without cellular atypia) but you will need to exclude an endometrium carcinoma (a formal diagnosis is only possible with a biopsy).

19
Q

What is the ultrasound appearance of adenomyomosis?

A

Echogenic linear striations (Venetian blind) extending from endometrium into myo.
Hyperechoic islands
Irregular endo-myo junction
Tiny anechoic myo and sub endo cysts reflecting fluid in the glands
Cystic striations
Myosis - muscular hyperplasia +/- hypertrophy may be hypoechoic
Focal/diffuse myometrial bulkiness that can be asymmetrical
Generally increased vascularity

20
Q

Describe the normal endometrium appearance during the menstural, proliferative and secretory phase

A

M: 0.5-1mm thin echogenic line
P: 4-8mm, hypoechoic thickening
S: 7-14mm hyperechoic thickening

21
Q

List the signs of menopause

A

Fewer follicles grow
Supply depleted
Gonad, FSH, LH raise in an attempt to stimulate follicles.
When these hormones are raised,it is evidence of ovarian failure

22
Q

List the sonographic appearance of the ovary in the premenopausal woman

A

Follicular: Many follicles (>5+), increasing in size until day 8/9 in which one follicle become dominant and the other atretic, grows 1-2mm per day
Pre-ovulatory: dominant follicle measures 20-25mm
Luteal phase: corpus luteum, 20mm, irregular hypo/iso cyst often with low level echoes, typical ring of fire vascularity

23
Q

What is dysmenorrhea

A

Painful menstural period

24
Q

What is oligomenorrhoea

A

Occasional occurrence of menses

25
Q

What is polymenorrhoea

A

Menses interval <21 days

26
Q

What is hypermenorrhoea / menorrhagia?

A

Prolonged or increased uterine bleeding at regular intervals

27
Q

What is metorrhagia and menimetrorrhagia

A

Intermenstural bleeding at irregular intervals

Prolonged menstural flow and intermenstural bleeding

28
Q

What is dyspareunia

A

Pain during intercourse

29
Q

List the goals of Orval contraceptive pill useage

A
  1. Contraception by inhibiting ovulation
  2. Creates an endo lining that resists implantation
  3. Thickens cervical mucous which prevents sperm from entry

Most women will not develop a dominant follicle and ovulate.
The ovary appears homogenous with no dominant follicle

30
Q

What clinical conditions are seen less in those who iseOCP

A

Ectopic pregnancy
Ovarian cysts
PID
Iron deficiency
Decreased menstural symptoms / acne (combined)
Prolonged use combined OCP reduces risk of developing uterine myomata and ovarian/endo cancer

31
Q

Discuss symptoms related to decreased ovarian competence and oestrogen (seen in menopausal patients not taking (HRT)

A
  1. Disturbed menstural pattern
  2. Vasomotor instability (hot flashes / sweats)
  3. Psychological - anxiety, mood
  4. Atrophy conditions - skin, urinary, vulval, vaginal
  5. Health problems - secondary to long term deprivation of oestrogen, includes osteoporosis and CVD
32
Q

What is the aim of HRT?

A

Gives additional oestrogen to reduce effects / symptoms of insuffiencient oestrogen in the body

33
Q

HRT: oestrogen only vs Oestrogen + progesterone

A

E: increases ris of endometrial cancer
E + P: eliminates risk
Therefore combination should be given

34
Q

Discuss oestrogen only HRT

A

Oestrogen will prevent and reduce osteoporosis menstura; symptoms
However, increases risk of endo cancer during and after use
Patient normally feel fine without progesterone but after a duration of time, problems occur
30% patients using oestrogen only will develop atypical hyperplasia, a premalignancy
Ultrasound appearance: thick, hyperplastic endo with or without cellular atypica
Only way to exclude endometrial carcinoma is a formal biopsy